ALA.AX

Arovella Therapeutics Limited ALA.AX

ALA.AX
Arovella Therapeutics Limited SPL.AX
Starpharma Holdings Limited ATH.AX
Alterity Therapeutics Limited IMU.AX
Imugene Limited RCE.AX
Recce Pharmaceuticals Ltd ACW.AX
Actinogen Medical Limited EZZ.AX
EZZ Life Science Holdings Limited ILA.AX
Island Pharmaceuticals Limited BIO.AX
Biome Australia Limited ALC.AX
Alcidion Group Limited

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ALA.AX SPL.AX ATH.AX IMU.AX RCE.AX ACW.AX EZZ.AX ILA.AX BIO.AX ALC.AX
6M 17.95 % 170.83 % 71.43 % -54.66 % 41.38 % 0.00 % 68.35 % 118.75 % 4.49 % 25.00 %
YTD -45.88 % 136.36 % 33.33 % -72.18 % -16.33 % 15.38 % -10.74 % 112.12 % -22.50 % 55.74 %
1Y -52.82 % 179.57 % 300.00 % -77.84 % -26.79 % 15.38 % -35.75 % 100.00 % -34.97 % 66.67 %
3Y 217.24 % -59.69 % -7.69 % -93.60 % -37.26 % -72.46 % 772.13 % 121.72 % 511.84 % -29.63 %
5Y 124.39 % -82.43 % -73.33 % -80.93 % -64.04 % 31.94 % 129.31 % -28.21 % 287.50 % -25.51 %
10Y -83.37 % -63.89 % -90.00 % 22.00 % 38.03 % -45.23 % 129.31 % -28.21 % 287.50 % 115.20 %
From the beginning -97.20 % -69.41 % -97.60 % -99.55 % 38.03 % -95.44 % 129.31 % -28.21 % 287.50 % -44.00 %

Dividend

EZZ Life Science Holdings Limited